Why Invest in Elixinol Wellness Limited?
With more than 25 years’ experience in the hemp industry, Elixinol Wellness (ASX: EXL; OTCQB: ELLXF) is a trusted and established brand. Our hemp derived nutraceutical, skincare and food products offering, along with our strong innovation pipeline, reinforces our position as a global market leader in a high growth category.
According to the Brightfield Group, the US hemp derived CBD market reached US$4.2b in sales in 2019 and is expected to grow to US$16.8b by 2025, with a forecasted CAGR of 26% between 2020-2025. While in Europe the CBD market is expected to grow to $2.3b by 2025, with a five-year CAGR of 34%.
As we continue to expand our global presence via dedicated sales teams in the US, UK, Europe and Australia, we are strongly positioned to take full advantage of the hemp market’s huge growth potential.
View our shareholder services here.